Total Funding
4
Total FundingSeed raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Equinext LLC develops technologies for the treatment of ligament and tendon injuries in horses.
Rick Schackel: CFO- Eric Hauck: Chairman & CEO
About the Company
Equinext, LLC develops technologies for the treatment of ligament and tendon injuries in horses in the United States. It offers nonsurgical exogenous crosslink therapy (NEXT), a chemically made device formed following injection of a crosslinking agent into the lesion of the tendon or ligament that interacts with the native proteins (collagen). The
company’s products are also used to treat the causes of wobbler’s disease and intervertebral disc degradation. It has strategic partnership with Hagyard Equine Medical Institute. The company was incorporated in 2011 and is based in Lexington, Kentucky.
